Schedule 13D ownership disclosure
ADVERUM BIOTECHNOLOGIES INC
Security class unavailable · CUSIP: 00773U108
Event date: 2022-12-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,552,068
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-22-000761
- Form type
- SC 13D
- Filer
- Adverum Biotechnologies, Inc.
- CIK
- CIK 1501756
- Filed
- Dec 30, 2022
- Reporting period
- Dec 27, 2022
- Description
- Schedule 13D beneficial ownership